Abstract
A healthy 5-year-old girl developed myalgia and an elevated creatine kinase concentration after 4 days of normal doses of clarithromycin. Myalgias resolved and creatine kinase values returned to normal following discontinuation of clarithromycin. No other precipitating factors or interacting drugs were identified; hence, clarithromycin was suspected as the cause of the rhabdomyolysis.
| Original language | English |
|---|---|
| Pages (from-to) | 216-7 |
| Number of pages | 2 |
| Journal | The Journal of Pediatric Pharmacology and Therapeutics |
| Volume | 16 |
| Issue number | 3 |
| Publication status | Published - 2011 |
Keywords
- adverse drug event
- clarithromycin
- pediatric
- rhabdomyolysis